Iambic and NVIDIA: Using AI to chart a faster course for drug discovery

Press

This is some text inside of a div block.

June 17, 2024

Media Contacts

Related announcements

View All

Iambic Therapeutics Closes $50 million Series B Extension to Broaden its Pipeline of AI-Discovered Clinical Oncology Programs

Iambic Therapeutics Closes $50 million Series B Extension to Broaden its Pipeline of AI-Discovered Clinical Oncology Programs

How two academic chemists turned San Diego startup Iambic into an AI force

How two academic chemists turned San Diego startup Iambic into an AI force

Iambic Therapeutics Announces Poster Presentation for IAM1363, a Clinical Stage Type II HER2 Inhibitor, at the 2024 ASCO Annual Meeting

Iambic Therapeutics Announces Poster Presentation for IAM1363, a Clinical Stage Type II HER2 Inhibitor, at the 2024 ASCO Annual Meeting